Scientists reveal direct link between mitochondrial DNA mutations and cancer treatment response

Cancer Research UK-funded scientists have made an unusual discovery that could help to identify patients who are up to two and a half times more likely to respond to currently available cancer drugs.

Alvotech receives another CRL from the FDA for Humira biosimilar candidate

Biosimilar developer Alvotech has once again been handed a complete response letter from the FDA. On Wednesday, the company announced that it received a rejection

June 30, 2023

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of

July 10, 2023

ERS Roundup: Air Filtration Succeeds in Reducing Infections

Research presented at the annual European Respiratory Society (ERS) congress in Vienna included studies on air filtration for reducing infections in day care, betamethasone for

September 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.